PRTN3 and rheumatoid arthritis: The ACPA-positive patients were taking significantly (p = 0.040) more non-steroidal anti-inflammatory drugs (NSAIDs) compared to the ACPA-negative subjects with RA (37% versus 0%, respectively) (Supplementary Table S2).